December 23, 2024 08:12 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait | Jaipur gas tanker crash: Toll touches 14, 30 critical | Arrest warrant against former cricketer Robin Uthappa over 'PF fraud' | PM Modi emplanes for a visit to Kuwait | German Christmas market car attack leaves 2 dead, Saudi Arabian doctor arrested | India, France come together to build world's largest museum in Delhi's Raisina Hill | Canada, US presented no evidence of Indians' involvement in purported criminal acts: Centre informs Parliament amid 'serious allegations' | Delhi Police Crime Branch to investigate FIR against Rahul Gandhi over Parliament tussle
COVID19

COVID-19: More than 11.70 lakh samples tested for 2 consecutive days

| @indiablooms | Sep 04, 2020, at 09:08 pm

After having successfully achieved the goal of enhancing the daily testing capacity to more than 10 lakhs daily tests, India has scaled new peaks in COVID-19 testing for the last two successive days.

For these two successive days, more than 11.70 lakh samples have been tested across the country. 11,69,765 samples were tested in the last 24 hours.

No other country has achieved these levels of very high daily testing.

With this steep exponential rise in daily testing, the cumulative tests are nearing 4.7 crore. The cumulative tests as on date have reached 4,66,79,145.

Even with this very high daily testing, the daily Positivity Rate is still below 7.5%, while cumulative Positivity Rate is less than 8.5%.

The sustained higher testing on a wide scale enables early diagnosis, prompt isolation and timely hospitalisation. Effective treatment based on Standard Treatment Protocol both in supervised home isolation and in hospitals, also results in lower mortality rate.

With the aim to reduce the fatality rate below 1%, India’s Case Fatality Rate (CFR) has touched 1.74% following a gradient of steady and sustained decline.

India’s substantial increase in the testing levels is anchored in the daily expanding diagnostic lab network across the country.

As on date, with 1025 labs in the government sector and 606 private labs, the country-wide network is strengthened with 1631 total lab facilities.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.